Role of natural killer and Gamma-delta T cells in West Nile virus infection

Viruses

Volumn 5, Issue 9, 2013, Pages 2298-2310

  Wang, Tian ^a   Welte, Thomas ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Gamma delta T cells; Natural killer cells; West nile virus

Indexed keywords

ADAPTIVE IMMUNITY; CELL KILLING; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GAMMA DELTA T LYMPHOCYTE; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; NATURAL KILLER CELL; NONHUMAN; PROTECTION; REVIEW; VIRUS CELL INTERACTION; VIRUS LOAD; VIRUS PATHOGENESIS; WEST NILE FEVER; WEST NILE FLAVIVIRUS;

ANIMALS; HUMANS; KILLER CELLS, NATURAL; MICE; T-LYMPHOCYTES; WEST NILE FEVER; WEST NILE VIRUS;

EID: 84884626368     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v5092298     Document Type: Review

References (94)

1. Kramer, L.D.; Styer, L.M.; Ebel, G.D. A global perspective on the epidemiology of West Nile virus. Annu. Rev. Entomol. 2008, 53, 61-81.
2. Campbell, G.L.; Marfin, A.A.; Lanciotti, R.S.; Gubler, D.J. West Nile virus. Lancet Infect. Dis. 2002, 2, 519-529.
3. Centers for Disease Control and Prevention (CDC). Possible West Nile virus transmission to an infant through breast-feeding-Michigan, 2002. MMWR Morb. Mortal. Wkly. Rep. 2002, 51, 877-878.
4. Centers for Disease Control and Prevention (CDC). Laboratory-acquired West Nile virus infections-United States, 2002. MMWR Morb. Mortal. Wkly. Rep. 2002, 51, 1133-1135.
5. Alpert, S.G.; Fergerson, J.; Noel, L.P. Intrauterine West Nile virus: Ocular and systemic findings. Am. J. Ophthalmol. 2003, 136, 733-735.
6. Charatan, F. Organ transplants and blood transfusions may transmit West Nile virus. Br. Med. J. 2002, 325, PMCID:PMC1169473.
7. Carson, P.J.; Konewko, P.; Wold, K.S.; Mariani, P.; Goli, S.; Bergloff, P.; Crosby, R.D. Long-term clinical and neuropsychological outcomes of West Nile virus infection. Clin. Infect. Dis. 2006, 43, 723-730.
8. Ravindra, K.V.; Freifeld, A.G.; Kalil, A.C.; Mercer, D.F.; Grant, W.J.; Botha, J.F.; Wrenshall, L.E.; Stevens, R.B. West Nile virus-associated encephalitis in recipients of renal and pancreas transplants: Case series and literature review. Clin. Infect. Dis. 2004, 38, 1257-1260.
9. Ou, A.C.; Ratard, R.C. One-year sequelae in patients with West Nile virus encephalitis and meningitis in Louisiana. J. La. State Med. Soc. 2005, 157, 42-46.
10. Cook, R.L.; Xu, X.; Yablonsky, E.J.; Sakata, N.; Tripp, J.H.; Hess, R.; Piazza, P.; Rinaldo, C.R. Demographic and clinical factors associated with persistent symptoms after West Nile virus infection. Am. J. Trop. Med. Hyg. 2010, 83, 1133-1136.
11. Sadek, J.R.; Pergam, S.A.; Harrington, J.A.; Echevarria, L.A.; Davis, L.E.; Goade, D.; Harnar, J.; Nofchissey, R.A.; Sewell, C.M.; Ettestad, P.; et al. Persistent neuropsychological impairment associated with West Nile virus infection. J. Clin. Exp. Neuropsychol. 2010, 32, 81-87.
12. Davis, B.S.; Chang, G.J.; Cropp, B.; Roehrig, J.T.; Martin, D.A.; Mitchell, C.J.; Bowen, R.; Bunning, M.L. West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays. J. Virol. 2001, 75, 4040-4047.
13. Kramer, L.D.; Bernard, K.A. West Nile virus infection in birds and mammals. Ann. NY Acad. Sci. 2001, 951, 84-93.
14. Ratterree, M.S.; Gutierrez, R.A.; Travassos da Rosa, A.P.; Dille, B.J.; Beasley, D.W.; Bohm, R.P.; Desai, S.M.; Didier, P.J.; Bikenmeyer, L.G.; Dawson, G.J.; et al. Experimental infection of rhesus macaques with West Nile virus: Level and duration of viremia and kinetics of the antibody response after infection. J. Infect. Dis. 2004, 189, 669-676.
15. Xiao, S.Y.; Guzman, H.; Zhang, H.; Travassos da Rosa, A.P.; Tesh, R.B. West Nile virus infection in the golden hamster (Mesocricetus auratus): A model for West Nile encephalitis. Emerg. Infect. Dis. 2001, 7, 714-721.
16. Beasley, D.W.; Li, L.; Suderman, M.T.; Barrett, A.D. Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype. Virology 2002, 296, 17-23.
17. Wang, T.; Anderson, J.F.; Magnarelli, L.A.; Wong, S.J.; Koski, R.A.; Fikrig, E. Immunization of mice against West Nile virus with recombinant envelope protein. J. Immunol. 2001, 167, 5273-5277.
18. Sun, J.C.; Lanier, L.L. Natural killer cells remember: An evolutionary bridge between innate and adaptive immunity? Eur. J. Immunol. 2009, 39, 2059-2064.
19. Bonneville, M.; O'Brien, R.L.; Born, W.K. Gammadelta T cell effector functions: A blend of innate programming and acquired plasticity. Nat. Rev. Immunol. 2010, 10, 467-478.
20. Shen, Y.; Zhou, D.; Qiu, L.; Lai, X.; Simon, M.; Shen, L.; Kou, Z.; Wang, Q.; Jiang, L.; Estep, J.; et al. Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections. Science 2002, 295, 2255-2258.
21. Colonna, M.; Jonjic, S.; Watzl, C. Natural killer cells: Fighting viruses and much more. Nat. Immunol. 2011, 12, 107-110.
22. Vivier, E.; Tomasello, E.; Baratin, M.; Walzer, T.; Ugolini, S. Functions of natural killer cells. Nat. Immunol. 2008, 9, 503-510.
23. Martins, M.A.; Silva, M.L.; Eloi-Santos, S.M.; Ribeiro, J.G.; Peruhype-Magalhaes, V.; Marciano, A.P.; Homma, A.; Kroon, E.G.; Teixeira-Carvalho, A.; Martins-Filho, O.A. Innate immunity phenotypic features point toward simultaneous raise of activation and modulation events following 17DD live attenuated yellow fever first-time vaccination. Vaccine 2008, 26, 1173-1184.
24. Sooryanarain, H.; Ayachit, V.; Gore, M. Activated CD56(+) lymphocytes (NK+NKT) mediate immunomodulatory and anti-viral effects during Japanese encephalitis virus infection of dendritic cells in vitro. Virology 2012, 432, 250-260.
25. Vargin, V.V.; Semenov, B.F. Changes of natural killer cell activity in different mouse lines by acute and asymptomatic flavivirus infections. Acta Virol. 1986, 30, 303-308.
26. Kurane, I.; Hebblewaite, D.; Brandt, W.E.; Ennis, F.A. Lysis of dengue virus-infected cells by natural cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity. J. Virol. 1984, 52, 223-230.
27. Brehin, A.C.; Mouries, J.; Frenkiel, M.P.; Dadaglio, G.; Despres, P.; Lafon, M.; Couderc, T. Dynamics of immune cell recruitment during West Nile encephalitis and identification of a new CD19+B220-BST-2+ leukocyte population. J. Immunol. 2008, 180, 6760-6767.
28. Liu, Y.; Blanden, R.V.; Mullbacher, A. Identification of cytolytic lymphocytes in West Nile virus-infected murine central nervous system. J. Gen. Virol. 1989, 70, 565-573.
29. Zhang, M.; Daniel, S.; Huang, Y.; Chancey, C.; Huang, Q.; Lei, Y.F.; Grinev, A.; Mostowski, H.; Rios, M.; Dayton, A. Anti-West Nile virus activity of in vitro expanded human primary natural killer cells. BMC Immunol. 2010, 11, doi:10.1186/1471-2172-11-3.
30. Liu, Y.; Mullbacher, A. Astrocytes are not susceptible to lysis by natural killer cells. J. Neuroimmunol. 1988, 19, 101-110.
31. Shrestha, B.; Samuel, M.A.; Diamond, M.S. CD8+ T Cells require perforin to clear West Nile virus from infected neurons. J. Virol. 2006, 80, 119-129.
32. Shi, F.D.; Ljunggren, H.G.; la Cava, A.; van Kaer, L. Organ-specific features of natural killer cells. Nat. Rev. Immunol. 2011, 11, 658-671.
33. Trifilo, M.J.; Montalto-Morrison, C.; Stiles, L.N.; Hurst, K.R.; Hardison, J.L.; Manning, J.E.; Masters, P.S.; Lane, T.E. CXC chemokine ligand 10 controls viral infection in the central nervous system: evidence for a role in innate immune response through recruitment and activation of natural killer cells. J. Virol. 2004, 78, 585-594.
34. Hao, J.; Liu, R.; Piao, W.; Zhou, Q.; Vollmer, T.L.; Campagnolo, D.I.; Xiang, R.; la Cava, A.; van Kaer, L.; Shi, F.D. Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology. J. Exp. Med. 2010, 207, 1907-1921.
35. Krueger, P.D.; Lassen, M.G.; Qiao, H.; Hahn, Y.S. Regulation of NK cell repertoire and function in the liver. Crit. Rev. Immunol. 2011, 31, 43-52.
36. Suthar, M.S.; Brassil, M.M.; Blahnik, G.; McMillan, A.; Ramos, H.J.; Proll, S.C.; Belisle, S.E.; Katze, M.G.; Gale, M., Jr. A systems biology approach reveals that tissue tropism to West Nile virus is regulated by antiviral genes and innate immune cellular processes. PLoS Pathog. 2013, 9, e1003168.
37. Lobigs, M.; Blanden, R.V.; Mullbacher, A. Flavivirus-induced up-regulation of MHC class I antigens; implications for the induction of CD8+ T-cell-mediated autoimmunity. Immunol. Rev. 1996, 152, 5-19.
38. Ye, J.; Zhu, B.; Fu, Z.F.; Chen, H.; Cao, S. Immune evasion strategies of flaviviruses. Vaccine 2013, 31, 461-471.
39. Kesson, A.M.; Cheng, Y.; King, N.J. Regulation of immune recognition molecules by flavivirus, West Nile. Viral. Immunol. 2002, 15, 273-283.
40. Mullbacher, A.; Lobigs, M. Up-regulation of MHC class I by flavivirus-induced peptide translocation into the endoplasmic reticulum. Immunity 1995, 3, 207-214.
41. Cheng, Y.; King, N.J.; Kesson, A.M. Major histocompatibility complex class I (MHC-I) induction by West Nile virus: Involvement of 2 signaling pathways in MHC-I up-regulation. J. Infect. Dis. 2004, 189, 658-668.
42. Larena, M.; Regner, M.; Lobigs, M. Cytolytic effector pathways and IFN-gamma help protect against Japanese encephalitis. Eur. J. Immunol. 2013, 43, 1789-1798.
43. Biron, C.A.; Nguyen, K.B.; Pien, G.C. Innate immune responses to LCMV infections: Natural killer cells and cytokines. Curr. Top. Microbiol. Immunol. 2002, 263, 7-27.
44. Sivori, S.; Falco, M.; Della Chiesa, M.; Carlomagno, S.; Vitale, M.; Moretta, L.; Moretta, A. CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: Induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc. Natl. Acad. Sci. USA 2004, 101, 10116-10121.
45. Vivier, E.; Nunes, J.A.; Vely, F. Natural killer cell signaling pathways. Science 2004, 306, 1517-1519.
46. Hershkovitz, O.; Rosental, B.; Rosenberg, L.A.; Navarro-Sanchez, M.E.; Jivov, S.; Zilka, A.; Gershoni-Yahalom, O.; Brient-Litzler, E.; Bedouelle, H.; Ho, J.W.; et al. NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells. J. Immunol. 2009, 183, 2610-2621.
47. Hayday, A.C. Gammadelta cells: A right time and a right place for a conserved third way of protection. Annu. Rev. Immunol. 2000, 18, 975-1026.
48. Wang, L.; Kamath, A.; Das, H.; Li, L.; Bukowski, J.F. Antibacterial effect of human V gamma 2V delta 2 T cells in vivo. J. Clin. Invest. 2001, 108, 1349-1357.
49. Ferrick, D.A.; King, D.P.; Jackson, K.A.; Braun, R.K.; Tam, S.; Hyde, D.M.; Beaman, B.L. Intraepithelial gamma delta T lymphocytes: Sentinel cells at mucosal barriers. Springer Semin. Immunopathol. 2000, 22, 283-296.
50. O'Brien, R.L.; Roark, C.L.; Born, W.K. IL-17-producing gammadelta T cells. Eur. J. Immunol. 2009, 39, 662-666.
51. Heilig, J.S.; Tonegawa, S. Diversity of murine gamma genes and expression in fetal and adult T lymphocytes. Nature 1986, 322, 836-840.
52. Huber, S.A.; Graveline, D.; Newell, M.K.; Born, W.K.; O'Brien, R.L. V gamma 1+ T cells suppress and V gamma 4+ T cells promote susceptibility to coxsackievirus B3-induced myocarditis in mice. J. Immunol. 2000, 165, 4174-4181.
53. Ninomiya, T.; Takimoto, H.; Matsuzaki, G.; Hamano, S.; Yoshida, H.; Yoshikai, Y.; Kimura, G.; Nomoto, K. Vgamma1+ gammadelta T cells play protective roles at an early phase of murine cytomegalovirus infection through production of interferon-gamma. Immunology 2000, 99, 187-194.
54. Wang, T.; Scully, E.; Yin, Z.; Kim, J.H.; Wang, S.; Yan, J.; Mamula, M.; Anderson, J.F.; Craft, J.; Fikrig, E. IFN-gamma-producing gammadelta T cells help control murine West Nile virus infection. J. Immunol. 2003, 171, 2524-2531.
55. Shrestha, B.; Wang, T.; Samuel, M.A.; Whitby, K.; Craft, J.; Fikrig, E.; Diamond, M.S. Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection. J. Virol. 2006, 80, 5338-5348.
56. Welte, T.; Lamb, J.; Anderson, J.F.; Born, W.K.; O'Brien, R.L.; Wang, T. Role of two distinct gammadelta T cell subsets during West Nile virus infection. FEMS Immunol. Med. Microbiol. 2008, 53, 275-283.
57. Sciammas, R.; Kodukula, P.; Tang, Q.; Hendricks, R.L.; Bluestone, J.A. T cell receptor gammadelta cells protect mice from herpes simplex virus type 1-induced lethal encephalitis. J. Exp. Med. 1997, 185, 1969-1975.
58. Selin, L.K.; Santolucito, P.A.; Pinto, A.K.; Szomolanyi-Tsuda, E.; Welsh, R.M. Innate immunity to viruses: Control of vaccinia virus infection by gamma delta T cells. J. Immunol. 2001, 166, 6784-6794.
59. Tseng, C.T.; Klimpel, G.R. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J. Exp. Med. 2002, 195, 43-49.
60. Kesson, A.M.; Blanden, R.V.; Mullbacher, A. The primary in vivo murine cytotoxic T cell response to the flavivirus, West Nile. J. Gen. Virol. 1987, 68, 2001-2006.
61. Brien, J.D.; Uhrlaub, J.L.; Nikolich-Zugich, J. West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection. J. Immunol. 2008, 181, 8568-8575.
62. Welte, T.; Wang, T. University of Texas Medical Branch, Galveston, TX, USA. Unpublished work, 2013.
63. Wang, T.; Gao, Y.; Scully, E.; Davis, C.T.; Anderson, J.F.; Welte, T.; Ledizet, M.; Koski, R.; Madri, J.A.; Barrett, A.; et al. Gammadelta T cells facilitate adaptive immunity against West Nile virus infection in mice. J. Immunol. 2006, 177, 1825-1832.
64. Fang, H.; Welte, T.; Zheng, X.; Chang, G.J.; Holbrook, M.R.; Soong, L.; Wang, T. gammadelta T cells promote the maturation of dendritic cells during West Nile virus infection. FEMS Immunol. Med. Microbiol. 2010, 59, 71-80.
65. Wang, T.; Fikrig, E. Immunity to West Nile virus. Curr. Opin. Immunol. 2004, 16, 519-523.
66. Hayes, E.B.; Gubler, D.J. West Nile virus: Epidemiology and clinical features of an emerging epidemic in the United States. Annu. Rev. Med. 2006, 57, 181-194.
67. Brien, J.D.; Uhrlaub, J.L.; Hirsch, A.; Wiley, C.A.; Nikolich-Zugich, J. Key role of T cell defects in age-related vulnerability to West Nile virus. J. Exp. Med. 2009, 206, 2735-2745.
68. Kunzmann, V.; Bauer, E.; Feurle, J.; Weissinger, F.; Tony, H.P.; Wilhelm, M. Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood 2000, 96, 384-392.
69. Wilhelm, M.; Kunzmann, V.; Eckstein, S.; Reimer, P.; Weissinger, F.; Ruediger, T.; Tony, H.P. Gammadelta T cells for immune therapy of patients with lymphoid malignancies. Blood 2003, 102, 200-206.
70. Wang, S.; Welte, T.; Fang, H.; Chang, G.J.; Born, W.K.; O'Brien, R.L.; Sun, B.; Fujii, H.; Kosuna, K.; Wang, T. Oral administration of active hexose correlated compound enhances host resistance to West Nile encephalitis in mice. J. Nutr. 2009, 139, 598-602.
71. Welte, T.; Aronson, J.; Gong, B.; Rachamallu, A.; Mendell, N.; Tesh, R.; Paessler, S.; Born, W.K.; O'Brien, R.L.; Wang, T. Vgamma4+ T cells regulate host immune response to West Nile virus infection. FEMS Immunol. Med. Microbiol. 2011, 63, 183-192.
72. Wang, T.; Town, T.; Alexopoulou, L.; Anderson, J.F.; Fikrig, E.; Flavell, R.A. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 2004, 10, 1366-1373.
73. Weaver, C.T.; Hatton, R.D.; Mangan, P.R.; Harrington, L.E. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 2007, 25, 821-852.
74. DiTirro, J.; Rhoades, E.R.; Roberts, A.D.; Burke, J.M.; Mukasa, A.; Cooper, A.M.; Frank, A.A.; Born, W.K.; Orme, I.M. Disruption of the cellular inflammatory response to Listeria monocytogenes infection in mice with disruptions in targeted genes. Infect. Immun. 1998, 66, 2284-2289.
75. Bai, F.; Town, T.; Qian, F.; Wang, P.; Kamanaka, M.; Connolly, T.M.; Gate, D.; Montgomery, R.R.; Flavell, R.A.; Fikrig, E. IL-10 signaling blockade controls murine West Nile virus infection. PLoS Pathog. 2009, 5, e1000610.
76. Schneider, B.S.; McGee, C.E.; Jordan, J.M.; Stevenson, H.L.; Soong, L.; Higgs, S. Prior exposure to uninfected mosquitoes enhances mortality in naturally-transmitted West Nile virus infection. PLoS One 2007, 2, e1171.
77. Hahn, Y.S.; Ji, X.Y.; Woo, S.I.; Choi, Y.K.; Song, M.S.; Shin, K.S.; Jin, N.; O'Brien, R.L.; Born, W.K. Vgamma1+ gammadelta T cells reduce IL-10-producing CD4+CD25+ T cells in the lung of ovalbumin-sensitized and challenged mice. Immunol. Lett. 2008, 121, 87-92.
78. O'Brien, R.L.; Yin, X.; Huber, S.A.; Ikuta, K.; Born, W.K. Depletion of a gamma delta T cell subset can increase host resistance to a bacterial infection. J. Immunol. 2000, 165, 6472-6479.
79. Born, W.K.; O'Brien, R.L. Antigen-restricted gammadelta T-cell receptors? Arch. Immunol. Ther. Exp. 2009, 57, 129-135.
80. Iwasaki, A.; Medzhitov, R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 2004, 5, 987-995.
81. Akira, S.; Hemmi, H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol. Lett. 2003, 85, 85-95.
82. Beetz, S.; Marischen, L.; Kabelitz, D.; Wesch, D. Human gamma delta T cells: Candidates for the development of immunotherapeutic strategies. Immunol. Res. 2007, 37, 97-111.
83. Beetz, S.; Wesch, D.; Marischen, L.; Welte, S.; Oberg, H.H.; Kabelitz, D. Innate immune functions of human gammadelta T cells. Immunobiology 2008, 213, 173-182.
84. Shimura, H.; Nitahara, A.; Ito, A.; Tomiyama, K.; Ito, M.; Kawai, K. Up-regulation of cell surface Toll-like receptor 4-MD2 expression on dendritic epidermal T cells after the emigration from epidermis during cutaneous inflammation. J. Dermatol. Sci. 2005, 37, 101-110.
85. Peng, G.; Wang, H.Y.; Peng, W.; Kiniwa, Y.; Seo, K.H.; Wang, R.F. Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway. Immunity 2007, 27, 334-348.
86. Town, T.; Bai, F.; Wang, T.; Kaplan, A.T.; Qian, F.; Montgomery, R.R.; Anderson, J.F.; Flavell, R.A.; Fikrig, E. Toll-like receptor 7 mitigates lethal West Nile encephalitis via interleukin 23-dependent immune cell infiltration and homing. Immunity 2009, 30, 242-253.
87. Daffis, S.; Samuel, M.A.; Suthar, M.S.; Gale, M., Jr.; Diamond, M.S. Toll-like receptor 3 has a protective role against West Nile virus infection. J. Virol. 2008, 82, 10349-10358.
88. Welte, T.; Reagan, K.; Fang, H.; Machain-Williams, C.; Zheng, X.; Mendell, N.; Chang, G.J.; Wu, P.; Blair, C.D.; Wang, T. Toll-like receptor 7-induced immune response to cutaneous West Nile virus infection. J. Gen. Virol. 2009, 90, 2660-2668.
89. Szretter, K.J.; Daffis, S.; Patel, J.; Suthar, M.S.; Klein, R.S.; Gale, M., Jr.; Diamond, M.S. The innate immune adaptor molecule MyD88 restricts West Nile virus replication and spread in neurons of the central nervous system. J. Virol. 2010, 84, 12125-12138.
90. Zhang, J.; Wang, J.; Xie, G.; Wang, T. University of Texas Medical Branch, Galveston, TX, USA. Unpublished work, 2013.
91. Pietschmann, K.; Beetz, S.; Welte, S.; Martens, I.; Gruen, J.; Oberg, H.H.; Wesch, D.; Kabelitz, D. Toll-like receptor expression and function in subsets of human gammadelta T lymphocytes. Scand. J. Immunol. 2009, 70, 245-255.
92. Wesch, D.; Beetz, S.; Oberg, H.H.; Marget, M.; Krengel, K.; Kabelitz, D. Direct costimulatory effect of TLR3 ligand poly(I:C) on human gamma delta T lymphocytes. J. Immunol. 2006, 176, 1348-1354.
93. Kunzmann, V.; Kretzschmar, E.; Herrmann, T.; Wilhelm, M. Polyinosinic-polycytidylic acid-mediated stimulation of human gammadelta T cells via CD11c dendritic cell-derived type I interferons. Immunology 2004, 112, 369-377.
94. Devilder, M.C.; Allain, S.; Dousset, C.; Bonneville, M.; Scotet, E. Early triggering of exclusive IFN-gamma responses of human Vgamma9Vdelta2 T cells by TLR-activated myeloid and plasmacytoid dendritic cells. J. Immunol. 2009, 183, 3625-3633.